TherapeuticsMD, Inc. (NYSE MKT: TXMD), a women's healthcare company (the "Company" or "TherapeuticsMD"), announced today that the Company will present at the 25
Annual Piper Jaffray Healthcare Conference taking place at The New York Palace on December 3-4, 2013 in New York City.
Robert Finizio, Chief Executive Officer and Co-Founder of TherapeuticsMD, will present on Wednesday, December 4, 2013 at 4:00 p.m. EST.
During the presentation, material information concerning the Company, its operations, strategies and prospects may be discussed. To listen to the live audio webcast of the presentation during the event, please visit:
. A replay of the webcast will be available for 30 days after the initial presentation.
About TherapeuticsMD, Inc.
TherapeuticsMD, Inc. is a women’s healthcare company focused on developing and commercializing products targeted exclusively for women. We are developing advanced hormone therapy pharmaceutical products based on novel technologies that enable delivery of bioidentical hormones through a variety of dosage forms and administration routes. We also manufacture and distribute branded and generic prescription prenatal vitamins, as well as over-the-counter vitamins and cosmetics, under our vitaMedMD
brands. More information is available at the following websites: